Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.15.1 (
ACE
)
18,300
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A polymorphic variant of the human
angiotensin converting enzyme
(
ACE
) gene was identified. The 'D' (rather than 'I') variant was associated with improvements in strength related to physical training. We set out to determine whether the response to different patterns of strength training might also differ. Ninty-nine Caucasian male non-elite athletes were randomly allocated into one of three groups: 31 non-training/control (CG: 31), single-set (SSG: 35) and multiple-set (MSG: 33). SSG and MSG trained three times a week for 6 weeks. Both training groups were underwent a strength-training program with two mesocycles (12-15 repetition maximum (RM) and 8-12 RM mesocycles). One RM loads in half squat and bench press were assessed before training and after the first and second mesocycles.
ACE
polymorphisms analysed by polymerase chain reaction (PCR) methods. Subjects with
ACE
II genotype in the
MST
group had improved strength development in 12-15 RM, while SST and
MST
groups had similar gains in 8-12 RM. Subjects with
ACE
DD genotype in both the SSG and the MSG had similar benefits from both 12-15 RM and 8-12 RM. Strength gains for subjects with
ACE
ID genotype in the SSG were similar to MSG gains in response to 8-12 RM loads but not with 12-15 RM loads. Additionally, subjects with DD genotype had superior strength gains in both strength training groups. Tailoring strength training programmes (single-set vs. multiple set) according to the athlete's
ACE
genotype may be advantageous.
...
PMID:ACE genotype may have an effect on single versus multiple set preferences in strength training. 1600 39
Angiotensin I-Converting Enzyme (
ACE
, CD143
) Gene plays a crucial role in the pathology of carcinomas in many cancers including colorectal cancer (CRC). However, the methylation of
ACE
was rarely reported. In this study, our purpose was to investigate the methylation status of
ACE
and explored its prognostic value in CRC. The expression of
ACE
was detected by quantitative real-time polymerase chain reaction (qRT-PCR) analysis while the methylation status of
ACE
was measured via methylation-specific polymerase chain reaction (MSP). The result demonstrated that
ACE
expression was up-regulated in tumour tissues and HT-29 cells compared with the controls.
ACE
was also confirmed to be hypomethylated in CRC. Next, we evaluated the influence of
ACE
hypomethylation on cell growth. It was proved to be a favourable factor for the cell proliferation, cell colony forming, but an inhibitor for the cell apoptosis of CRC cells according to
MST
assay, colony forming assay and flow cytometry assay.
ACE
hypomethylation was also considered to be related to the prognosis of CRC through Cox regression analysis. Taken together, the over-expression of
ACE
was regulated by its hypomethylation and the
ACE
hypomethylation might be an independent prognostic indicator in CRC.
...
PMID:Angiotensin I-converting enzyme gene plays a crucial role in the pathology of carcinomas in colorectal cancer. 3120 48